Concomitant administration of proton pump inhibitors does not significantly affect clinical outcomes in metastatic breast cancer patients treated with ribociclib

BACKGROUND: Gastric pH changes by proton-pump-inhibitors (PPIs) were found to affect progression-free survival (PFS) in metastatic breast cancer (mBC) patients treated with palbociclib. The current study was aimed at investigating whether the same effect could occur in patients treated with ribocicl...

Descripción completa

Detalles Bibliográficos
Autores principales: Del Re, Marzia, Crucitta, Stefania, Omarini, Claudia, Bargagna, Irene, Mongillo, Marta, Palleschi, Michela, Stucci, Stefania, Meattini, Icro, D'Onofrio, Raffaella, Lorenzini, Giulia, Biondani, Pamela, De Giorgi, Ugo, Porta, Camillo, Livi, Lorenzo, Natalizio, Salvatore, Fontana, Andrea, Giontella, Elena, Angelini, Lucia, Fogli, Stefano, Danesi, Romano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9593796/
https://www.ncbi.nlm.nih.gov/pubmed/36283134
http://dx.doi.org/10.1016/j.breast.2022.10.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9593796/
https://www.ncbi.nlm.nih.gov/pubmed/36283134
http://dx.doi.org/10.1016/j.breast.2022.10.005

Ejemplares similares